Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Inventory (2021 - 2024)

PAVmed (PAVM) has 4 years of Inventory data on record, last reported at $687000.0 in Q2 2024.

  • For Q2 2024, Inventory changed N/A year-over-year to $687000.0; the TTM value through Jun 2024 reached $687000.0, changed N/A, while the annual FY2023 figure was $278000.0, 150.45% up from the prior year.
  • Inventory reached $687000.0 in Q2 2024 per PAVM's latest filing, up from $410000.0 in the prior quarter.
  • Across five years, Inventory topped out at $687000.0 in Q2 2024 and bottomed at $50000.0 in Q3 2021.
  • Average Inventory over 4 years is $307200.0, with a median of $278000.0 recorded in 2023.
  • The widest YoY moves for Inventory: up 150.45% in 2023, down 150.45% in 2023.
  • A 4-year view of Inventory shows it stood at $50000.0 in 2021, then soared by 122.0% to $111000.0 in 2022, then skyrocketed by 150.45% to $278000.0 in 2023, then soared by 147.12% to $687000.0 in 2024.
  • Per Business Quant database, its latest 3 readings for Inventory were $687000.0 in Q2 2024, $410000.0 in Q1 2024, and $278000.0 in Q4 2023.